May 30th, 2008
No more heart disease
IRVINE, Calif., May 30 /PRNewswire-FirstCall/ — Edwards Lifesciences Corporation (NYSE: EW), a world leader in products and technologies to treat advanced cardiovascular disease, said today that it has received additional questions from the U.S Source: www.forbes.com
PROMACTA(R) (eltrombopag) RECEIVES UNANIMOUS RECOMMENDATION BY FDA - ForbesPanel Votes, 16-0, in Favor of Short-Term […]